Novo Nordisk Investor
Novo Nordisk is a healthcare company that produces and distributes insulin and other diabetes drugs to treat chronic diseases. Its main offerings include pioneering scientific breakthroughs and expanding access to their medicines, with the ultimate goal of preventing and curing disease.
Number Of Exists:
4
Industry:
Regenerative Medicine
Founded Date:
1923-01-01
Investor Type:
Private Equity Funds
Headquarters:
Bagsværd,Hovedstaden,Denmark,Europe
Funding Status:
public